Kotak fund injects $109m into Indian IPO-hopeful Neuberg Diagnostics

Kotak Investment Advisors Limited (KIAL), the alternative assets arm of Kotak Mahindra Group, said it has invested Rs 940 crore ($109.4 million) in India’s Neuberg Diagnostics, as it readies itself to list on the Indian bourses.